NexgenRx (NXG) Insider Trading & Ownership C$0.26 -0.01 (-3.70%) As of 01/28/2025 09:30 AM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider Trades NexgenRx (CVE:NXG) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage36.79%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)C$38,600.00Number OfInsiders Selling(Last 12 Months)0 Get NXG Insider Trade Alerts Want to know when executives and insiders are buying or selling NexgenRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NXG Insider Buying and Selling by Quarter NexgenRx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2024Paul CrossettInsiderBuy20,000C$0.25C$5,000.005/24/2024Ronald Campbell LoucksDirectorBuy120,000C$0.28C$33,600.00 (Data available from 1/1/2013 forward) NXG Insider Trading Activity - Frequently Asked Questions Who is on NexgenRx's Insider Roster? The list of insiders at NexgenRx includes Kelly Tyler Ehler, Paul Crossett, and Ronald Campbell Loucks. Learn more on insiders at NXG. What percentage of NexgenRx stock is owned by insiders? 36.79% of NexgenRx stock is owned by insiders. Learn more on NXG's insider holdings. Which NexgenRx insiders have been buying company stock? The following insiders have purchased NXG shares in the last 24 months: Paul Crossett (C$5,000.00), and Ronald Campbell Loucks (C$33,600.00). How much insider buying is happening at NexgenRx? Insiders have purchased a total of 140,000 NXG shares in the last 24 months for a total of C$38,600.00 bought. NexgenRx Key ExecutivesMr. Ronald C. Loucks B.B.A. (Age 74)Founder, CEO, President & Director Compensation: $313.34kMr. Kelly Elher C.A.CPA, CA, CPA, Chief Financial OfficerMr. Andrew MunroeSenior Vice President of Pharma & Payor PartnersMr. Jason RobinsonSenior Vice President of AdministrationMs. Doreen HarveyLead Human ResourcesMr. Paul Anthony Bolger LL.B.M.B.A., Company SecretaryMr. Avik DebroyFinancial Controller More Insider Trading Tools from MarketBeat Related Companies Theralase Technologies Insider Ownership Microbix Biosystems Insider Ownership Sernova Insider Ownership KDA Group Insider Ownership Aurora Spine Insider Ownership Hemostemix Insider Ownership Decibel Cannabis Insider Ownership DIAGNOS Insider Ownership Nova Leap Health Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (CVE:NXG) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
